Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net loss	$ (21,541)	$ (4,224)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of acquisition-related intangible assets	10,251	10,171
Stock-based compensation plan expense	27,569	22,146
Depreciation and other amortization	19,075	16,032
Gain on sale of cost-method investment	(80)	0
Deferred income tax benefit	(643)	(125)
Change in provision for allowances on accounts receivable	(273)	165
Amortization of debt issuance costs	228	206
Amortization of premium on investments	48	25
Fair value adjustment on other investments	(52)	0
Gain on other investments	0	(174)
Loss on disposal of equipment	4	23
Gain on foreign exchange	(449)	(34)
Changes in operating assets and liabilities:
Accounts receivable	(364)	(139)
Prepaid expenses and other current assets	(1,569)	(2,935)
Operating lease right-of-use asset, net	(1,324)	2,438
Other assets	213	(2,950)
Accounts payable	39	(1,041)
Accrued expenses	7,337	(1,707)
Operating lease liabilities	2,022	(1,383)
Customer account liabilities	2,333	2,599
Deferred revenue	(14,065)	(14,842)
Other liabilities	(329)	(74)
Net cash provided by operating activities	28,430	24,177
Investing activities:
Acquisition of businesses and assets, net of cash acquired	(15,115)	(9,892)
Investment distributions received	161	0
Purchases of other investments	(35)	(7,150)
Issuance of note receivable	0	(2,600)
Purchases of available-for-sale securities	(900)	(8,203)
Proceeds from sales of available-for-sale securities	8,100	8,100
Capital expenditures, including capitalization of software costs	(20,052)	(14,980)
Net cash used in investing activities	(27,841)	(34,725)
Financing activities:
Repurchase of common stock	(50,000)	(10,755)
Repayment of amounts borrowed under revolving credit facility	0	(50,000)
Proceeds from exercise of stock options and employee stock purchase plan	2,313	2,169
Net cash used in financing activities	(47,687)	(58,586)
Effect of exchange rate changes on cash	(951)	7,774
Decrease in cash, cash equivalents and restricted cash	(48,049)	(61,360)
Cash, cash equivalents and restricted cash at beginning of period	143,768	201,136
Cash, cash equivalents and restricted cash at end of period	95,719	139,776
Cash and cash equivalents at end of period	83,726	130,096
Cash held for customers at end of period	11,993	9,680
Cash, cash equivalents and restricted cash at end of period	95,719	139,776
Supplemental disclosures of non-cash investing activities:
Issuance of common stock in connection with acquisition	$ 0	$ 8,183